HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 9372682)

Published in Am J Respir Crit Care Med on November 01, 1997

Authors

M Berlin1, A Fogdell-Hahn, O Olerup, A Eklund, J Grunewald

Author Affiliations

1: Department of Medicine, Karolinska Hospital, Stockholm, Sweden.

Articles citing this

Ocular involvement in sarcoidosis. Br J Ophthalmol (2000) 1.91

Sex-specific manifestations of Löfgren's syndrome. Am J Respir Crit Care Med (2006) 1.74

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet (2003) 1.57

Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PLoS One (2012) 1.23

Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol (2008) 1.10

Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol (2006) 1.06

Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax (2001) 1.00

A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans. Genes Immun (2010) 0.94

Granuloma formation in pulmonary sarcoidosis. Front Immunol (2013) 0.93

Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol (2008) 0.92

Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res (2010) 0.90

Surfactant gene polymorphisms and interstitial lung diseases. Respir Res (2001) 0.87

Epidemiology of familial sarcoidosis in the UK. Thorax (2000) 0.87

No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis. Respir Res (2010) 0.87

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet (2010) 0.87

Gene-environment interactions in sarcoidosis: challenge and opportunity. Clin Dermatol (2007) 0.86

Sarcoidosis: Immunopathogenesis and Immunological Markers. Int J Chronic Dis (2013) 0.85

Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans. Tissue Antigens (2008) 0.84

Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan. Mol Vis (2009) 0.83

Infliximab therapy for hepatic and intestinal sarcoidosis. Gastroenterol Hepatol (N Y) (2007) 0.82

Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc (2007) 0.82

Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res (2001) 0.81

Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res (2009) 0.81

Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis. J Inflamm (Lond) (2015) 0.80

Genetic predisposition to respiratory diseases: infiltrative lung diseases. Respiration (2007) 0.79

The saga of MHC-bound peptides: a renaissance for antigen presentation? J Clin Invest (2007) 0.79

Sarcoidosis in patients with mixed connective tissue disease: clinical, genetic, serological and histological observations. Rheumatol Int (2008) 0.78

SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations. Front Immunol (2017) 0.75

Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples. Mol Cell Proteomics (2016) 0.75

Mass Cytometry Identifies Distinct Lung CD4(+) T Cell Patterns in Löfgren's Syndrome and Non-Löfgren's Syndrome Sarcoidosis. Front Immunol (2017) 0.75

[Sarcoidosis : Renal manifestations]. Z Rheumatol (2017) 0.75

Articles by these authors

ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69

Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis (2008) 2.27

Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes. Arthritis Rheum (1991) 2.20

Two fatalities from ingestion of acetonitrile: limited specificity of analysis by headspace gas chromatography. J Anal Toxicol (1992) 2.09

HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 2.05

Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J (2003) 1.97

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens (2000) 1.82

Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med (1999) 1.76

T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type. J Exp Med (1991) 1.69

Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol (2000) 1.67

Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J (2005) 1.62

Distribution of toxaphene, DDT, and PCB among lipoprotein fractions in rat and human plasma. Arch Toxicol (1990) 1.57

Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J (1997) 1.54

Risk of tuberculosis in a large sample of patients with coeliac disease--a nationwide cohort study. Aliment Pharmacol Ther (2011) 1.54

Germ-line polymorphism of TCR genes and disease susceptibility--fact or hypothesis? Immunol Today (1992) 1.53

Changes in immune regulation in response to examination stress in atopic and healthy individuals. Clin Exp Allergy (2006) 1.52

Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol (1994) 1.51

Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci U S A (1990) 1.45

Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology (2003) 1.45

Pulmonary reactions caused by welding-induced decomposed trichloroethylene. Chest (1991) 1.44

T-cell receptor alpha chain germline gene polymorphisms in multiple sclerosis. Neurology (1992) 1.43

Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax (2006) 1.41

[GHB--dangerous, addictive and uncontrollable "party drug"]. Lakartidningen (2001) 1.40

Measurement of CSF dynamics with oscillating pressure infusion. Acta Neurol Scand (2012) 1.40

Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med (1999) 1.37

Neutralizing antibodies against interferon β: fluctuation is modest and titre dependent. Eur J Neurol (2008) 1.37

Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol (1992) 1.35

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35

Randomized clinical trial of Lichtenstein patch or Prolene Hernia System for inguinal hernia repair. Br J Surg (2006) 1.34

Spin torque-generated magnetic droplet solitons. Science (2013) 1.33

Randomized controlled multicenter international clinical trial of self-gripping Parietex™ ProGrip™ polyester mesh versus lightweight polypropylene mesh in open inguinal hernia repair: interim results at 3 months. Hernia (2012) 1.32

Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J (Clin Res Ed) (1985) 1.31

Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol (1992) 1.31

Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun (1993) 1.31

The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens (1995) 1.29

Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax (1986) 1.28

T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21

Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med (2001) 1.19

Road tunnel air pollution induces bronchoalveolar inflammation in healthy subjects. Eur Respir J (2007) 1.13

Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med (2001) 1.12

Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci U S A (1992) 1.11

T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci U S A (1994) 1.11

Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol (2008) 1.10

Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med (2000) 1.10

Dissolution of metals by human and rabbit alveolar macrophages. Br J Ind Med (1985) 1.10

Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy (2012) 1.08

Present progress towards the laboratory colonization of African Simuliidae (Diptera). Tropenmed Parasitol (1975) 1.07

Inflammatory cell response in bronchoalveolar lavage fluid after nitrogen dioxide exposure of healthy subjects: a dose-response study. Eur Respir J (1991) 1.05

An immunogenetic heterogeneity in multiple sclerosis. J Neurol Neurosurg Psychiatry (1992) 1.04

Tuberculostearic acid in lymph nodes from patients with sarcoidosis. Sarcoidosis (1987) 1.04

CSF pressure assessed by lumbar puncture agrees with intracranial pressure. Neurology (2007) 1.04

No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid. Eur J Respir Dis (1987) 1.03

Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax (2002) 1.02

Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax (1999) 1.02

Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur J Immunol (1992) 1.01

Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema. Eur Respir J (2005) 1.01

Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes. Immunol Rev (1990) 1.00

X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev (1994) 1.00

Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung. Allergy (2009) 0.99

Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J (1998) 0.98

T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol (1995) 0.98

Cellular and humoral immune responses to Plasmodium falciparum gametocyte antigens in malaria-immune individuals. Limited response to the 48/45-kilodalton surface antigen does not appear to be due to MHC restriction. J Immunol (1990) 0.98

Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation. Tissue Antigens (2003) 0.98

MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum. Int Immunol (1992) 0.97

Failure to detect MHC class II associations of the human immune response induced by repeated malaria infections to the Plasmodium falciparum antigen Pf155/RESA. Int Immunol (1991) 0.97

Is the PiF allele of alpha 1-antitrypsin associated with pulmonary disease? Clin Genet (1984) 0.97

Phenotypic analysis of alveolar macrophages and lymphocytes following allergen inhalation by atopic subjects with mild asthma. Respir Med (2005) 0.96

HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis. Eur Respir J (2011) 0.96

Alterations in bronchoalveolar lavage fluid but not in lung function and bronchial responsiveness in swine confinement workers. Chest (1992) 0.96

Extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis and their relationship to signs of alveolitis. Am Rev Respir Dis (1990) 0.95

The CTLA-4 gene is associated with multiple sclerosis. J Neuroimmunol (1999) 0.95

DR "low-resolution" PCR-SSP typing--a correction and an up-date. Tissue Antigens (1993) 0.95

Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med (2003) 0.95

Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J (2006) 0.94

Analysis of gamma delta V region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometry. Clin Exp Immunol (1995) 0.94

Measuring pulsatile flow in cerebral arteries using 4D phase-contrast MR imaging. AJNR Am J Neuroradiol (2013) 0.94